Topics
April 2012 | global Perspectives
Intravitreal Bevacizumab for Vitreous Hemorrhage Secondary to PDR
Andres Amaya Espinosa, MD; Gina Baron Mendoza, MD; Maria Alejandra Toro Millan, MD; and Natalia Camacho Espinosa, MD
March 2012 | global Perspectives
Treatment of Polypoidal Choroidal Vasculopathy
Individualized plans may be warranted, as the disease course can vary.
Won Ki Lee, MD
September 16, 2026
Ocular Therapeutix Completes Pre-NDA Meeting with FDA for Axpaxli in Wet AMD
September 15, 2026
Moorfields Study: Retinal Biomarkers May Signal Atrial Fibrillation Years Before Diagnosis
Nanoscope to Present Long-Term MCO-010 Data at the Retina Society Meeting
September 11, 2026
Galimedix Therapeutics to Present Functional Feasibility Data from Phase 2 eDREAM study in GA at Euretina
September 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Editorially independent supported by Abbvie and Regenxbio
September 2026 Supplement
Editorially independent content supported with advertising by Eyepoint
This activity is supported by an independent educational grant from AlconVision, LLC
View Program
This program will open on EvolveMedEd.com.
Free Print Subscription
Email Newsletter
Conference Calendar
